Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03354949 |
Other study ID # |
GHIV0117 |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
September 1, 2016 |
Est. completion date |
February 11, 2020 |
Study information
Verified date |
February 2021 |
Source |
Groupement Hospitalier Intercommunal du Vexin |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The investigators looked at the population of hemiplegic stroke participants hospitalized
with GHIV : the investigators assessed the postural control of the participants of the chair
using MCPAA, and assessed the pain of the participants while sitting in a wheelchair. The
investigators then had to the participants try positioning equipment and then prescribed it
once the choice was made. The investigators then reassessed postural control and wheelchair
pain with this positioning equipment.
Description:
For each hemiplegic participants with wheelchair user stroke, the investigators collect :
date of birth, date of stroke, side of hemiplegia. The wheelchair propulsion mode, the degree
of autonomy (FAC and Enjalber scales), the way bed - wheelchair transfers are made.
Assessment of wheelchair pain in the spine and Ischia with EVA. Time to travel 10 meters in a
wheelchair. Postural control of the wheelchair is evaluated by the MCPAA. The investigators
then carry out tests of positioning equipment : backrest, cushion, form elements and belt.
This material is tried for several days. If it is appropriate (improvement on the postural
control and on the pains), otherwise another material is tried.
When the choice is made, the material is prescribed. The participant is seen again 3 months
after the delivery of his personal material, and the same evaluation is redone.